argenx SE (ARGX.BR) — Stock Score Summary

argenx SE (ARGX.BR) has a MoatMap StockRank of 57/100 based on Quality (56/100), Value (23/100), and Momentum (64/100) factor scores. The current signal is HOLD. argenx is a high-quality commercial-stage immunology biotech, but it is a drug developer rather than a CDMO, meaning it does not directly capture the CDMO pricing power cycle theme.

argenx SE is a global immunology biotechnology company focused on developing antibody-based therapies for severe autoimmune diseases. The company's flagship product, Vyvgart (efgartigimod), is a first-in-class neonatal Fc receptor (FcRn) blocker with approved indications in generalized myasthenia gravis. Its competitive advantage lies in its proprietary SIMPLE Antibody platform and a rapid clinical expansion strategy targeting multiple multi-billion-dollar autoimmune indications.

Key Financial Metrics

Price$812.29
Market Cap$52.0B
P/E (TTM)37.04
P/E (Forward)23.16
Price/Book7.05
Return on Invested Capital17.4%
Debt/Equity0.64
Gross Margin58.1%
Operating Margin30.0%
Revenue Growth62.6%

argenx SE operates in the Biotechnology industry, part of the Healthcare sector (Netherlands).

Frequently Asked Questions

What is argenx SE’s (ARGX.BR) StockRank?
MoatMap’s StockRank for argenx SE (ARGX.BR) is 57/100, with a Hold signal. It is a composite of Quality (56), Value (23), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does argenx SE have an economic moat?
argenx SE (ARGX.BR) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is argenx SE a buy, hold, or sell?
MoatMap’s current signal for argenx SE (ARGX.BR) is Hold, based on a StockRank of 57/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is argenx SE in?
argenx SE (ARGX.BR) operates in the Healthcare sector, specifically the Biotechnology industry (Netherlands).
Browse all ranked stocksARGX.BR deep dive reportAI ChampionsHow we score stocksSense-check another stock